Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of Autologous Bone Marrow Derived Mononuclear Cells in Liver Cirrhosis

NCT00382278 is registered in ClinicalTrials.gov with Universidade Federal do Rio de Janeiro as lead sponsor.

NCT NCT00382278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of Autologous Bone Marrow Derived Mononuclear Cells in Liver Cirrhosis
Lead sponsor
Universidade Federal do Rio de Janeiro
Phase
Phase 1/2
Overall status
Terminated
Start date
November 30, 2005
Completion date
February 29, 2008
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis